Glycosylated Hemoglobin and C-Peptide Market Set to Reach US$ 9.94...

ha aggiunto una foto Altre informazioni

2026-04-30 13:41:22

Glycosylated Hemoglobin and C-Peptide Market Set to Reach US$ 9.94 Billion by 2034

The glycosylated hemoglobin (HbA1c) and C-peptide market is gaining significant momentum as the global burden of diabetes continues to rise. These diagnostic biomarkers play a crucial role in monitoring long-term glucose control and assessing pancreatic beta-cell function. Increasing awareness about early diabetes diagnosis, coupled with technological advancements in diagnostic tools, is...

0 Commenti 0 condivisioni 310 Views 0 Anteprima